US

Stage Ventures Partners targets $75 mln for third fund

Stage Venture Partners is seeking to raise $75 million for its third fund, according to an SEC filing. The Los Angeles venture firm invests in enterprise software.

Abivas grabs funding

Abivas, a French clinical-stage biotechnology company harnessing the immune system to develop novel treatments for inflammatory diseases, viral diseases and cancer, has secured 12 million euros in funding. The investor was Sofinnova Partners.

Microphyt locks in $32 mln

Microphyt, a French provider of microalgae-based natural solutions for nutrition and well-being, has raised $32 million in funding. Sofinnova Partners and BPI France led the round.

Sofinnova Partners leads Series A round for DMC

DMC, an early-stage biotech company, has secured an undisclosed amount of Series A funding. Sofinnova Partners led the round.

Node inks $16 mln

Node, an artificial intuition platform provider, has raised $16 million in financing. The investors include Mark Cuban, Avalon Ventures, New Enterprise Associates, NewView Capital, GingerBread Capital, Canaan Partners, JetBlue Technology Ventures, Will Smith’s Dreamers Fund, MS&AD, Wharton Alumni Fund, Plum Alley and former Google and Microsoft executive James Whittaker.

SupplyCompass to secure seed funding

London and Mumbai-based SupplyCompass, a design-to-delivery sourcing platform, has agreed to raise 1.5 million pounds in seed funding. Episode 1 is the lead investor.

Anish Acharya joins a16z to focus on fintech

Andreessen Horowitz announced that it’s expanding its fintech team with the addition of Anish Acharya as the firm’s newest general partner. Acharya was formerly with Credit Karma, where he most recently was vice president of product. Acharya will focus on fintech, working alongside fellow a16z General Partners Angela Strange and Alastair "Alex" Rampell.

SynergySuite picks up $6 mln Series A

SynergySuite, a cloud-based restaurant management platform, has raised $6 million in Series A funding. First Analysis led the round with participation from Oyster Capital.

Demetrix nabs $50 mln Series A

Emeryville, California-based Demetrix Inc, a biotechnology company focused on the production of cannabinoids, has secured $50 million in Series A funding. Tuatara Capital led the round with participation from return backer Horizons Ventures.

Minerva Project lands $57 mln Series C

Minerva Project, a provider of top-tier educational offerings, has raised $57 million in Series C funding. Bytedance led the round.